Home » Healthcare » Pharmaceuticals » Turkey Gastrointestinal Products Market

Turkey Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Turkey gastrointestinal products market Size 2023	USD 89.26 million
Turkey gastrointestinal products market, CAGR	4.05%
Turkey gastrointestinal products market Size 2032	USD 127.89 million

Market Overview

The Turkey gastrointestinal products market is projected to grow from USD 89.26 million in 2023 to USD 127.89 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.05%.

The Turkey gastrointestinal products market is driven by an increasing prevalence of gastrointestinal disorders, fueled by unhealthy dietary habits, stress, and sedentary lifestyles. Growing awareness about early diagnosis and treatment, coupled with advancements in healthcare infrastructure, has bolstered demand for these products. The rising geriatric population, more prone to gastrointestinal ailments, further supports market growth. Additionally, government initiatives to improve healthcare accessibility and a growing trend toward over-the-counter medications contribute significantly. The introduction of innovative drug formulations and probiotics has gained traction, aligning with the shift toward preventive healthcare and wellness. Increasing adoption of digital health technologies, including telemedicine, has also improved patient access to gastrointestinal treatments. Moreover, partnerships between pharmaceutical companies and healthcare providers are enhancing product availability, while a focus on localized manufacturing strengthens the domestic market. These factors collectively underline the robust growth trajectory of gastrointestinal products in Turkey, meeting evolving healthcare demands.

The geographical analysis of Turkey’s gastrointestinal products market reveals significant regional demand driven by urban centers such as Istanbul, Ankara, and Izmir, where advanced healthcare infrastructure and growing awareness about gastrointestinal disorders are prominent. These regions are witnessing a surge in the adoption of both diagnostic devices and therapeutic products. The key players in the market include leading companies such as Boston Scientific Corporation, KARL STORZ, PENTAX Medical, Medtronic, and Stryker, which offer a wide range of innovative gastrointestinal devices. Local players, alongside global pharmaceutical giants, contribute to a competitive market landscape. These companies are focusing on expanding their product portfolios, improving diagnostic accuracy, and enhancing treatment options. The increasing prevalence of gastrointestinal diseases and advancements in medical technology further fuel the growth of these key players in Turkey’s expanding healthcare sector.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Turkey gastrointestinal products market is projected to grow from USD 89.26 million in 2023 to USD 127.89 million by 2032, at a CAGR of 4.05%.
Increasing prevalence of gastrointestinal diseases is driving demand for diagnostic and therapeutic products.
Rising consumer preference for preventive healthcare solutions and natural products is boosting the market.
Technological advancements in gastrointestinal devices, including endoscopy and biopsy tools, are shaping market trends.
The market is highly competitive, with major players like Boston Scientific, Medtronic, and KARL STORZ leading the space.
High treatment costs and limited awareness in rural regions act as key market restraints.
Istanbul, Ankara, and Izmir dominate the market, with growing demand in other regions as healthcare accessibility improves.

Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

The rising prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) is a significant driver of the Turkey gastrointestinal products market. Changing dietary habits, a high intake of processed foods, and increased stress levels have led to a surge in these conditions among various age groups. Consequently, the growing patient population has intensified the demand for effective medications and treatments, further fueling market growth. Additionally, improved awareness regarding early diagnosis and the availability of advanced treatment options have contributed to the expanding consumption of gastrointestinal products.

Shift Toward Over-the-Counter (OTC) Products

The increasing preference for over-the-counter (OTC) gastrointestinal products reflects a shift toward self-medication and preventive healthcare in Turkey. Consumers are actively seeking convenient and affordable options for managing mild digestive disorders. This trend has encouraged pharmaceutical companies to focus on developing innovative and consumer-friendly products, including probiotics and antacids. For instance, the market for digestive and intestinal remedies in Turkey is projected to grow significantly, driven by consumer demand for OTC solutions. The ease of availability and widespread retail distribution of OTC products have amplified their adoption, positioning them as a key growth driver in the market.

Advancements in Healthcare Infrastructure

Turkey’s ongoing efforts to enhance its healthcare infrastructure have significantly impacted the gastrointestinal products market. For example, the Health Transformation Program initiated by the Turkish government has led to substantial improvements in healthcare access and quality. Investments in modern medical facilities, an increase in healthcare expenditure, and the implementation of universal health coverage have improved access to quality treatments for gastrointestinal disorders. Moreover, the government’s focus on expanding healthcare services in rural and underserved regions has further boosted the adoption of these products. As medical professionals increasingly rely on evidence-based treatments, demand for advanced gastrointestinal solutions continues to rise, strengthening market growth.

Rising Geriatric Population

The growing geriatric population in Turkey is another crucial factor driving the gastrointestinal products market. Older individuals are more susceptible to gastrointestinal conditions due to age-related changes in digestive function and the prevalence of comorbidities. As Turkey experiences demographic shifts with an increasing elderly population, the demand for specialized gastrointestinal treatments and preventive healthcare products has seen a substantial uptick. This demographic trend underscores the critical need for effective, safe, and accessible gastrointestinal medications and supplements.

Market Trends

Increased Focus on Local Manufacturing

The growing emphasis on localized manufacturing is reshaping the Turkey gastrointestinal products market. Domestic production reduces dependency on imports, ensures cost-effectiveness, and supports government initiatives to strengthen the pharmaceutical sector. For instance, Turkey has 105 pharmaceutical manufacturing facilities, with local firms playing a significant role. Local manufacturers are increasingly adopting international quality standards to meet global benchmarks, enhancing the competitiveness of Turkish products in regional and international markets. This focus on self-reliance is expected to sustain market growth while fostering innovation and job creation in the healthcare industry.

Rise in Digital Health Technologies

The adoption of digital health technologies is transforming the gastrointestinal products market in Turkey. Telemedicine platforms and health apps have made it easier for patients to consult specialists and receive timely advice on managing digestive health. This digital shift enhances awareness about gastrointestinal disorders and available treatments, leading to increased uptake of pharmaceutical and OTC products. Furthermore, healthcare providers are leveraging data analytics and artificial intelligence to personalize treatment plans, improving outcomes and driving demand for targeted gastrointestinal solutions.

Advancements in Drug Formulations

Innovative drug formulations and delivery systems are emerging as prominent trends in Turkey’s gastrointestinal products market. Pharmaceutical companies are focusing on developing products with enhanced bioavailability, reduced side effects, and improved patient compliance. For instance, the Turkish Medicine and Medical Devices Authority (TITCK) has recently updated guidelines to support the development of advanced drug formulations. Extended-release tablets, chewable formats, and liquid formulations are gaining popularity among diverse consumer groups. These advancements not only address the specific needs of patients but also create a competitive edge for manufacturers, enabling them to capture a larger market share.

Growing Demand for Probiotics and Nutraceuticals

The Turkey gastrointestinal products market is witnessing a significant shift toward probiotics and nutraceuticals, driven by the growing emphasis on preventive healthcare and wellness. Consumers increasingly prefer natural and functional products to support digestive health and overall well-being. Probiotics, known for their ability to restore gut flora and enhance digestion, have become a staple in addressing mild gastrointestinal issues. Additionally, nutraceuticals that combine therapeutic benefits with nutritional value are gaining traction, offering versatile solutions for consumers seeking long-term health benefits.

Market Challenges Analysis

High Cost of Advanced Treatments

One of the major challenges in the Turkey gastrointestinal products market is the high cost associated with advanced treatments and innovative drug formulations. For instance, the cost of gastrointestinal treatments in Turkey can be significantly high, with procedures like esophagectomy costing around $8,000. While newer therapies and medications offer enhanced efficacy and patient outcomes, their premium pricing makes them less accessible to a significant portion of the population. This issue is particularly pronounced among middle- and lower-income groups who rely on affordable treatment options. Additionally, limited insurance coverage for certain gastrointestinal treatments further exacerbates the financial burden on patients, restricting market growth. The need for cost-effective solutions that balance quality and accessibility remains a critical concern for healthcare providers and manufacturers.

Limited Awareness in Rural Areas

Despite advancements in healthcare infrastructure, limited awareness about gastrointestinal disorders and available treatments in rural and underserved areas presents a significant challenge. A lack of education and access to reliable healthcare information often delays diagnosis and treatment, allowing conditions to progress to more severe stages. Furthermore, logistical challenges in distributing pharmaceutical products to remote regions hinder market penetration. Addressing this gap requires targeted awareness campaigns, improved distribution networks, and initiatives to train local healthcare professionals. Overcoming these barriers is essential to ensure equitable access to gastrointestinal products across Turkey, driving sustained market growth.

Market Opportunities

Growing Demand for Preventive Healthcare Solutions

The Turkey gastrointestinal products market presents significant opportunities driven by the increasing consumer focus on preventive healthcare. Rising awareness about digestive health and the benefits of early intervention have fueled demand for probiotics, nutraceuticals, and other functional products that promote gut wellness. Consumers are actively seeking non-prescription, natural solutions to maintain digestive health, creating a lucrative avenue for manufacturers. Additionally, partnerships between pharmaceutical companies and retail chains have expanded the availability of over-the-counter (OTC) gastrointestinal products, further boosting their adoption. This trend aligns with the broader shift toward health-conscious living, offering immense growth potential for companies that innovate and diversify their product portfolios.

Expansion of Digital Health and Telemedicine

The rapid adoption of digital health technologies and telemedicine services in Turkey provides another promising growth opportunity for the gastrointestinal products market. Digital platforms enable patients to access healthcare services conveniently, enhancing awareness and diagnosis of gastrointestinal conditions. Teleconsultations and health monitoring apps are increasing patient engagement and facilitating the recommendation of tailored treatment options, including gastrointestinal products. Moreover, pharmaceutical companies can leverage these platforms to market their offerings directly to a tech-savvy consumer base. By integrating digital health solutions into their business strategies, manufacturers and healthcare providers can expand their reach and improve patient outcomes, fostering long-term market growth.

Market Segmentation Analysis:

By Devices:

The Turkey gastrointestinal products market is segmented by devices, including endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices dominate the segment due to their widespread use in diagnosing and treating gastrointestinal conditions, offering minimally invasive procedures that improve patient comfort and outcomes. Ablation devices are gaining traction in managing gastrointestinal cancers and other severe conditions, reflecting advancements in technology and their increasing adoption in therapeutic interventions. Motility testing devices play a critical role in assessing functional gastrointestinal disorders, enhancing diagnostic accuracy. Similarly, biopsy devices are essential for detecting malignant and non-malignant conditions, contributing to better clinical management. The growing adoption of stenting devices in addressing obstructive gastrointestinal diseases further underscores the demand for advanced therapeutic options. These devices collectively address the diverse needs of healthcare providers and patients, supporting market growth.

By Indications:

Based on indications, the Turkey gastrointestinal products market encompasses gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases. Gastrointestinal cancers represent a significant segment due to rising incidence rates and the need for targeted therapies and diagnostic tools. GERD and IBS are among the most prevalent conditions, driving consistent demand for effective treatments and devices that enhance patient quality of life. IBD, including Crohn’s disease and ulcerative colitis, accounts for a substantial share, given the increasing focus on specialized treatments and therapies. Other gastrointestinal disorders, such as peptic ulcers and infections, further expand the market scope. The diversity in indications emphasizes the need for versatile and innovative solutions, driving advancements in research and development and meeting Turkey’s growing healthcare demands.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Istanbul
Ankara
Izmir
Other

Regional Analysis

Istanbul

Istanbul holds the largest market share, accounting for approximately 35% of the Turkey gastrointestinal products market. This dominance is attributed to its position as the country’s economic and medical hub, supported by a well-established healthcare infrastructure and a high concentration of healthcare professionals. The city’s diverse population drives demand for a wide range of gastrointestinal products, including advanced diagnostic devices and over-the-counter solutions. Moreover, Istanbul’s pharmaceutical companies and research institutions contribute to the development and accessibility of innovative treatments. Rising awareness of digestive health and access to cutting-edge medical technologies further strengthen Istanbul’s market leadership.

Ankara

Ankara captures around 25% of the Turkey gastrointestinal products market, leveraging its role as the nation’s administrative and healthcare center. The city boasts some of the country’s most advanced hospitals and healthcare facilities, catering to a growing number of patients with gastrointestinal disorders. Government-backed initiatives to improve healthcare accessibility and affordability have significantly boosted product adoption in Ankara. Additionally, the city’s aging population, prone to gastrointestinal conditions, further drives demand for diagnostic tools and therapeutic solutions. With a strong emphasis on public health policies and medical tourism, Ankara continues to play a pivotal role in the market.

Izmir

Izmir accounts for approximately 15% of the market share, reflecting its growing prominence in Turkey’s gastrointestinal products landscape. As a key metropolitan area, Izmir benefits from robust healthcare services and a rising focus on wellness and medical tourism. The city is witnessing increased adoption of advanced diagnostic devices like endoscopy tools and therapeutic products due to improving healthcare awareness and accessibility. Investments in modern medical facilities and the promotion of preventive healthcare have further expanded the market potential in Izmir, solidifying its role as a critical

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Boston Scientific Corporation
KARL STORZ
PENTAX Medical
Zhejiang Tiansong Medical Instrument Co
Medtronic
Stryker
Smith & Nephew
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of Turkey’s gastrointestinal products market is shaped by several prominent global and local players, including Boston Scientific Corporation, KARL STORZ, PENTAX Medical, Medtronic, Stryker, Smith & Nephew, Hoya, and other regional companies. Leading companies in the sector focus on advancing diagnostic and therapeutic devices, such as endoscopy, biopsy, and ablation equipment, aimed at improving patient outcomes and healthcare efficiency. For instance, the Turkish Medicine and Medical Devices Agency (TITCK) has reported significant advancements in endoscopic technologies, which are now widely used in hospitals across Turkey. Companies are investing in research and development to offer advanced solutions that enhance precision, reduce recovery times, and support minimally invasive procedures, which are becoming increasingly popular in gastrointestinal treatments. Manufacturers are also emphasizing customer-centric approaches, such as offering user-friendly designs, high-quality imaging, and greater accessibility of products. Additionally, partnerships with healthcare providers and hospitals are essential for expanding product reach and ensuring effective implementation. Regional players complement the market by providing cost-effective alternatives tailored to local needs while maintaining compliance with international standards. The competitive edge in this market is driven by continuous product innovation, advancements in technology, and the ability to adapt to the growing demand for preventive and early diagnostic solutions. Companies are focusing on strategic expansions and marketing efforts to enhance brand visibility and strengthen their positions in an increasingly competitive environment.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The market concentration of Turkey’s gastrointestinal products sector is moderately fragmented, with both global and local companies playing significant roles. Major international players with advanced technologies and diverse product portfolios dominate the high-end segment, particularly in diagnostic and therapeutic devices like endoscopes, biopsy tools, and ablation devices. However, local manufacturers also contribute to the market by offering cost-effective alternatives and focusing on meeting region-specific needs. This balance of global innovation and local adaptability ensures a competitive environment, with companies striving to differentiate themselves through technological advancements, pricing strategies, and customer support. In terms of characteristics, the market is driven by growing demand for minimally invasive procedures and preventive healthcare solutions. Increasing awareness about gastrointestinal health, along with the rising prevalence of related diseases, is pushing healthcare providers to adopt advanced diagnostic and treatment technologies. The market is also characterized by strong collaborations between manufacturers and healthcare providers, ensuring that new products align with clinical needs and regulatory standards. Additionally, the increasing focus on digital healthcare solutions, such as telemedicine and online health consultations, is expected to influence market dynamics by enhancing product accessibility and patient engagement. Overall, the Turkish gastrointestinal products market is evolving with a focus on innovation, accessibility, and cost-effectiveness.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Turkey gastrointestinal products market is expected to continue its growth trajectory, driven by increasing healthcare access and awareness.
Advancements in minimally invasive procedures will propel demand for diagnostic and therapeutic devices.
Growing prevalence of gastrointestinal diseases, such as GERD, IBS, and gastrointestinal cancers, will further expand the market.
Demand for advanced imaging technologies, such as high-definition endoscopy, will increase as diagnostic accuracy improves.
The integration of artificial intelligence and digital tools into gastrointestinal devices will enhance diagnostic capabilities and patient outcomes.
There will be a rising focus on preventive healthcare, with more people seeking early detection of gastrointestinal disorders.
Regional expansion and improved healthcare infrastructure in underserved areas will increase the adoption of gastrointestinal products.
Technological innovations in smart devices and wearable health trackers will influence the market, allowing for continuous monitoring of gastrointestinal health.
The local production of gastrointestinal products is expected to rise, reducing dependency on imports and improving market accessibility.
Companies will increasingly focus on affordability and cost-effective solutions to meet the growing demand in both urban and rural regions

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. Turkey GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by Turkey 33

5.1.1. Turkey GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By Turkey, 2018 – 2023 33

5.2. Export Analysis by Turkey 34

5.2.1. Turkey GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By Turkey, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by Turkey 35

6.1.1. Turkey GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By Turkey, 2018 – 2023 35

6.2. Supply Analysis by Turkey 36

6.2.1. Turkey GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By Turkey, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by Turkey 37

7.1.1. Turkey GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By Turkey, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. Turkey GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. Turkey Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. Turkey GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. Turkey GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. Turkey GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. Turkey GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. Turkey GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. Turkey GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

Turkey Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Boston Scientific Corporation 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. KARL STORZ 78

16.3. PENTAX Medical 78

16.4. Zhejiang Tiansong Medical Instrument Co 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. Turkey GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Turkey GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for Turkey GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. Turkey GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By Turkey, 2018 – 2023 32

FIG NO. 5. Turkey GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By Turkey, 2018 – 2023 33

FIG NO. 6. Turkey GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By Turkey, 2018 – 2023 34

FIG NO. 7. Turkey GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By Turkey, 2018 – 2023 35

FIG NO. 8. Turkey GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By Turkey, 2018 – 2023 36

FIG NO. 9. Turkey GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Turkey GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Turkey GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Turkey GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Turkey GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Turkey GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Turkey GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Turkey GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Turkey GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Turkey GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Turkey GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. Turkey GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Turkey GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Turkey GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Turkey GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Turkey GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. Turkey GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. Turkey GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. Turkey GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. Turkey GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. Turkey GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. Turkey GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. Turkey GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. Turkey GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : Turkey GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : Turkey GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the Turkey Gastrointestinal Products market?

The Turkey gastrointestinal products market is currently valued at USD 89.26 million in 2023 and is projected to grow to USD 127.89 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.05%.

hat factors are driving the growth of the Turkey Gastrointestinal Products market?

The market growth is driven by the increasing prevalence of gastrointestinal disorders such as IBS, GERD, and IBD, fueled by unhealthy diets and stress. Growing awareness of early diagnosis, advancements in healthcare infrastructure, the aging population, and the shift toward over-the-counter (OTC) products and preventive healthcare solutions further support market expansion.

What are the key segments within the Turkey Gastrointestinal Products market?

The key segments include:
• By Devices: Endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices.
• By Indications: Gastrointestinal cancers, GERD, IBS, IBD, and other diseases.
• By End-User: Hospitals, ambulatory surgical centers, clinics, and other end users.
• By Geography: Major regions such as Istanbul, Ankara, Izmir, and others.

What are some challenges faced by the Turkey Gastrointestinal Products market?

Challenges include the high cost of advanced treatments, which limits accessibility for middle- and lower-income populations, and limited awareness about gastrointestinal disorders and treatments in rural areas. Logistical issues in distributing products to underserved regions also hinder market penetration.

Who are the major players in the Turkey Gastrointestinal Products market?

The major players include Boston Scientific Corporation, KARL STORZ, PENTAX Medical, Medtronic, and Stryker. Local manufacturers also contribute to the market by offering cost-effective solutions tailored to regional needs, creating a competitive landscape.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –